US Drug Recall Register
Class II · Moderate risk Terminated Initiated Apr 18, 2017 (9 years ago)

Alpha Lipoic Acid 25ml Mdv 25mg/Ml Inj

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

What was recalled

ALPHA LIPOIC ACID 25ML MDV 25MG/ML INJ, Injection, 25mg/mL, Rx only, 25 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

Recalling firm
Key Pharmacy and Compounding Center
Origin
WA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0758-2017

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Alpha recalls

See all
Class II · Moderate risk Ongoing

Naproxen Oral Suspension

Reason Chemical contamination; presence of lead and lithium above specification

Acella Pharmaceuticals, LLC NDC 42192-619-16 D-0523-2026
Class II · Moderate risk Ongoing

Doxycycline Hyclate Tablets

Reason Failed dissolution specifications: Stability testing found that the lot did not meet dissolution specifications.

Acella Pharmaceuticals, LLC NDC 42192-501-05 D-0014-2026
Class II · Moderate risk Terminated

Methylphenidate Hydrochloride

Reason Failed dissolution specifications: this product is being recalled due to this batch not meeting dissolution specifications.

Trigen Laboratories NDC 13811-708-10 D-0579-2024